|Podcasts|December 1, 2021
Navigating New State Drug Price Transparency Laws
Author(s)Model N
As the State Drug Pricing Transparency Program expands, what does that mean for manufacturers? Jesse Mendelsohn, Vice President, Centers of Excellence for Model N, the leader in cloud revenue management solutions for life science companies, discusses challenges for manufacturers as the State Price Transparency Program expands how they should plan for this change and the solutions they will need.
Advertisement
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Why Continuous Vendor Oversight Is Key to Healthcare Data Security
2
Optimizing Your CGT Commercial Distribution Strategy: Four Priorities for a Successful Launch
3
One Connection, Endless Impact: Improving Patient Medication Access
4
Lilly Reveals Plan for New $3 Billion Manufacturing Facility in the Netherlands
5
